Role of IL-17A, IL-17F, and the IL-17 Receptor in Regulating Growth-Related Oncogene-α and Granulocyte Colony-Stimulating Factor in Bronchial Epithelium: Implications for Airway Inflammation in Cystic Fibrosis 1

IL-17R signaling is critical for pulmonary neutrophil recruitment and host defense against Gram-negative bacteria through the coordinated release of G-CSF and CXC chemokine elaboration. In this study, we show that IL-17R is localized to basal airway cells in human lung tissue, and functional IL-17R signaling occurs on the basolateral surface of human bronchial epithelial (HBE) cells. IL-17A and IL-17F were potent inducers of growth-related oncogene-α and G-CSF in HBE cells, and significant synergism was observed with TNF-α largely due to signaling via TNFRI. The activities of both IL-17A and IL-17F were blocked by a specific anti-IL-17R Ab, but only IL-17A was blocked with a soluble IL-17R, suggesting that cell membrane IL-17R is required for signaling by both IL-17A and IL-17F. Because IL-17A and IL-17F both regulate lung neutrophil recruitment, we measured these molecules as well as the proximal regulator IL-23p19 in the sputum of patients with cystic fibrosis (CF) undergoing pulmonary exacerbation. We found significantly elevated levels of these molecules in the sputum of patients with CF who were colonized with Pseudomonas aeruginosa at the time of pulmonary exacerbation, and the levels declined with therapy directed against P. aeruginosa. IL-23 and the downstream cytokines IL-17A and IL-17F are critical molecules for proinflammatory gene expression in HBE cells and are likely involved in the proinflammatory cytokine network involved with CF pathogenesis.

[1]  K. Adler,et al.  A biphasic chamber system for maintaining polarity of differentiation of culture respiratory tract epithelial cells , 1988, In Vitro Cellular & Developmental Biology.

[2]  V. Wahn,et al.  Cytokines in neutrophil-dominated airway inflammation in patients with cystic fibrosis , 1995, European Archives of Oto-Rhino-Laryngology.

[3]  S. Gaffen,et al.  Cytokines link osteoblasts and inflammation: microarray analysis of interleukin‐17‐ and TNF‐α‐induced genes in bone cells , 2005, Journal of leukocyte biology.

[4]  M. Goldman,et al.  IL‐23 up‐regulates IL‐10 and induces IL‐17 synthesis by polyclonally activated naive T cells in human , 2005, European journal of immunology.

[5]  R. de Waal Malefyt,et al.  IL‐12 and IL‐23: master regulators of innate and adaptive immunity , 2004, Immunological reviews.

[6]  A. Lindén,et al.  Interleukin-17 family members and inflammation. , 2004, Immunity.

[7]  Hidetada Sasaki,et al.  Regulatory roles of IL-17 and IL-17F in G-CSF production by lung microvascular endothelial cells stimulated with IL-1β and/or TNF-α , 2004 .

[8]  J. Uddin,et al.  Defective lipoxin-mediated anti-inflammatory activity in the cystic fibrosis airway , 2004, Nature Immunology.

[9]  J. Shellito,et al.  Cutting Edge: Roles of Toll-Like Receptor 4 and IL-23 in IL-17 Expression in Response to Klebsiella pneumoniae Infection1 , 2003, The Journal of Immunology.

[10]  E. Lubberts The role of IL-17 and family members in the pathogenesis of arthritis. , 2003, Current opinion in investigational drugs.

[11]  T. Moseley,et al.  Interleukin-17 family and IL-17 receptors. , 2003, Cytokine & growth factor reviews.

[12]  S. Ferretti,et al.  IL-17, Produced by Lymphocytes and Neutrophils, Is Necessary for Lipopolysaccharide-Induced Airway Neutrophilia: IL-15 as a Possible Trigger , 2003, The Journal of Immunology.

[13]  A. Gurney,et al.  Interleukin-23 Promotes a Distinct CD4 T Cell Activation State Characterized by the Production of Interleukin-17* , 2003, The Journal of Biological Chemistry.

[14]  A. Andoh,et al.  Increased expression of interleukin 17 in inflammatory bowel disease , 2003, Gut.

[15]  J. Kolls,et al.  Interleukin-17: an emerging role in lung inflammation. , 2003, American journal of respiratory cell and molecular biology.

[16]  P. Hellings,et al.  Interleukin-17 orchestrates the granulocyte influx into airways after allergen inhalation in a mouse model of allergic asthma. , 2003, American journal of respiratory cell and molecular biology.

[17]  A. Lindén,et al.  Neutrophilic airway inflammation and IL‐17 , 2002, Allergy.

[18]  M. Konstan,et al.  The role of inflammation in the pathophysiology of CF lung disease , 2002, Clinical reviews in allergy & immunology.

[19]  R. Hromas,et al.  Cutting Edge: IL-17D, a Novel Member of the IL-17 Family, Stimulates Cytokine Production and Inhibits Hemopoiesis1 , 2002, The Journal of Immunology.

[20]  R. Coffman,et al.  New IL-17 Family Members Promote Th1 or Th2 Responses in the Lung: In Vivo Function of the Novel Cytokine IL-251 , 2002, The Journal of Immunology.

[21]  Katie Chan,et al.  Interleukin-17 stimulates the expression of interleukin-8, growth-related oncogene-alpha, and granulocyte-colony-stimulating factor by human airway epithelial cells. , 2002, American journal of respiratory cell and molecular biology.

[22]  Jorge R. Oksenberg,et al.  Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis , 2002, Nature Medicine.

[23]  M. Konstan,et al.  Prolonged inflammatory response to acute Pseudomonas challenge in interleukin-10 knockout mice. , 2002, American journal of respiratory and critical care medicine.

[24]  A. Gurney,et al.  IL‐17: prototype member of an emerging cytokine family , 2002, Journal of leukocyte biology.

[25]  M. Konstan,et al.  Murine models of CF airway infection and inflammation. , 2002, Methods in molecular medicine.

[26]  F. Accurso,et al.  Airway inflammation in children with cystic fibrosis and healthy children assessed by sputum induction. , 2001, American journal of respiratory and critical care medicine.

[27]  G. Sledge,et al.  Cutting Edge: IL-17F, a Novel Cytokine Selectively Expressed in Activated T Cells and Monocytes, Regulates Angiogenesis and Endothelial Cell Cytokine Production1 , 2001, The Journal of Immunology.

[28]  R. Kelley,et al.  IL‐17s adopt a cystine knot fold: structure and activity of a novel cytokine, IL‐17F, and implications for receptor binding , 2001, The EMBO journal.

[29]  J. Shellito,et al.  Requirement of Interleukin 17 Receptor Signaling for Lung Cxc Chemokine and Granulocyte Colony-Stimulating Factor Expression, Neutrophil Recruitment, and Host Defense , 2001, The Journal of experimental medicine.

[30]  J. Shellito,et al.  Interleukin-17 and lung host defense against Klebsiella pneumoniae infection. , 2001, American journal of respiratory cell and molecular biology.

[31]  J. Pilewski,et al.  Pharmacological modulation of ion transport across wild-type and DeltaF508 CFTR-expressing human bronchial epithelia. , 2000, American journal of physiology. Cell physiology.

[32]  J. Kolls,et al.  Requirement of Endogenous Stem Cell Factor and Granulocyte-Colony-Stimulating Factor for IL-17-Mediated Granulopoiesis1 , 2000, The Journal of Immunology.

[33]  M. Laan,et al.  Airway neutrophils and interleukin-17. , 2000, The European respiratory journal.

[34]  A. Gurney,et al.  Cloning and characterization of IL-17B and IL-17C, two new members of the IL-17 cytokine family. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[35]  J. Lötvall,et al.  Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways. , 1999, Journal of immunology.

[36]  A. Miller,et al.  IL-17 stimulates granulopoiesis in mice: use of an alternate, novel gene therapy-derived method for in vivo evaluation of cytokines. , 1998, Journal of immunology.

[37]  W. Fanslow,et al.  Human IL-17: a novel cytokine derived from T cells. , 1995, Journal of immunology.

[38]  George Kollias,et al.  The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor , 1995, Cell.